TaTME |
Transanal total mesorectal excision |
APE |
Abdominoperineal extirpation |
AR |
Anterior resection |
R1 |
Microscopic presence of tumor cells at the distal or circumferential resection margins or within a lymph node < 1 mm from the mesorectal fascia of the excised specimen |
CRM [+] |
Circumferential resection margin of the excised specimen [presence of tumor cells within 1 mm from the excised non-peritonealised surface of the rectum] |
DRM [+] |
Distal resection margin of the excised specimen [presence of tumor cells within 1 mm from the excised distal end of the specimen] |
Quality of TME specimen |
Using the Quirke grading system for completeness of mesorectal dissection, each TME specimen is graded as having either an intact mesorectum, minor or major defects.17
|
TNM-stage |
Classification of colorectal carcinoma (tumor, lymph nodes, metastasis) |
ARJ |
Anorectal junction (located approximately 3 cm proximal from AV) |
AV |
Anal valve |
EMVI |
Extra-mural vascular invasion (sign seen on MRI-imaging) |
Clavien–Dindo classification |
Ranking classification of postoperative complications, based on the therapy used for that specific complication |
1 |
Any deviation from the normal postoperative course without the need for pharmacological treatment or surgical, endoscopic and radiological interventions |
2 |
Requiring pharmacological treatment with drugs other than such allowed for grade I complications |
3a |
Requiring surgical, endoscopic or radiological intervention not under general anesthesia |
3b |
Requiring surgical, endoscopic or radiological intervention under general anesthesia |
4 |
Life-threatening complication requiring IC/ICU-management |
5 |
Death of a patient |